Immuron (ASX:IMC) develops research agreement

Biopharmaceutical company Immuron (IMC) has executed its previously announced research agreement involving the US Naval Medical Research Centre and the CSIRO.

This category is empty! Please try another category or use our search function to find what you are looking for. If you require further assistance please contact us.